PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 273 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 3.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $507,082 | -3.2% | 12,019 | -14.3% | 0.13% | -8.3% |
| Q4 2022 | $523,890 | -66.5% | 14,019 | -52.5% | 0.14% | -67.4% |
| Q3 2022 | $1,566,000 | +17.0% | 29,519 | +27.8% | 0.44% | +24.2% |
| Q2 2022 | $1,339,000 | -60.8% | 23,097 | -50.4% | 0.36% | -56.4% |
| Q1 2022 | $3,413,000 | -84.9% | 46,597 | -87.2% | 0.82% | +24.9% |
| Q4 2021 | $22,609,000 | +2097.2% | 364,376 | +1599.0% | 0.65% | +184.3% |
| Q3 2021 | $1,029,000 | -28.5% | 21,447 | -16.0% | 0.23% | -28.1% |
| Q2 2021 | $1,439,000 | -7.3% | 25,547 | +2.0% | 0.32% | -14.9% |
| Q1 2021 | $1,552,000 | – | 25,047 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |